Information Provided By: 
Fly News Breaks for July 20, 2018
CI, ESRX
Jul 20, 2018 | 08:36 EDT
As reported previously, Baird analyst Eric Coldwell downgraded Express Scripts (ESRX) to Neutral from Outperform as he believes the PBMs have been under heavy political attack in recent weeks and the stand-alone trajectory is hard to model right now. He said the share price upside is largely reliant on the successful completion of the Cigna (CI) transaction and downside risks have significantly increased. Coldwell has an $81 price target on Express Scripts shares.
News For ESRX;CI From the Last 2 Days
There are no results for your query ESRX;CI
